Access to a novel first-line single-tablet HIV antiretroviral regimen in Affordable Care Act Marketplace plans, 2018-2020.

Khazanchi, Rohan; Powers, Samuel; Killelea, Amy; Strumpf, Andrew; Horn, Tim; Hamp, Auntré; McManus, Kathleen A

Khazanchi, Rohan; Powers, Samuel; Killelea, Amy; Strumpf, Andrew; Horn, Tim; Hamp, Auntré; McManus, Kathleen A.

Afiliación

Khazanchi R; College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA.
Powers S; School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Killelea A; Harvard Internal Medicine-Pediatrics Residency Program, Brigham & Women's Hospital, Boston Children's Hospital, and Boston Medical Center, Boston, MA, USA.
Strumpf A; Departments of Internal Medicine and Pediatrics, Harvard Medical School, Boston, MA, USA.
Horn T; FXB Center for Health and Human Rights, Harvard University, Boston, MA, USA.
Hamp A; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, P.O. Box 801379, Charlottesville, VA, 22908, USA.
McManus KA; Health Systems and Policy, National Alliance of State and Territorial AIDS Directors (NASTAD), Washington, DC, USA.

J Pharm Policy Pract ; 16(1): 57, 2023 Apr 20.

Article en En | MEDLINE | ID: mdl-37081570

Palabras clave

Access to care; Coinsurance; Copay; Cost; Coverage; Drug pricing; HIV; Pharmacoequity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Pharm Policy Pract Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google